The Horizon Europe Cancer Mission Calls 2027 comprise six funding opportunities spanning cancer research, clinical trials, health systems and survivorship. The European Commission is scheduled to open applications on February 10, 2027.
Funding Topics
- Functional genomics: Identify new targets for cancer treatment.
- Clinical research in common cancers: Support studies led by Comprehensive Cancer Infrastructures.
- Rare cancers: Support phase 1 trials, including first-in-human studies, of biomarker-guided medicines or multimodal treatments for rare or very rare cancers and subtypes.
- Equity and patient outcomes: Use health economics, health systems and outcomes research to improve care and outcomes for people with cancer.
- Affordable cancer technologies: Support pre-commercial procurement of cancer technologies, medical devices or medicines.
- Young cancer survivors: Support a quality-of-life research programme through cancer charities and funding agencies.
Eligibility and Funding
- Eligibility, consortium requirements and budgets vary by topic. Check the individual call on the EU Funding & Tenders Portal before planning a proposal.
Key Dates
- Scheduled opening: February 10, 2027.
- Application deadline: September 16, 2027, at 5:00 p.m. CEST.